Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
68.38
+7.40 (12.14%)
Dec 8, 2025, 3:17 PM BST
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 711 employees as of September 30, 2025. The number of employees increased by 102 or 16.75% compared to the previous year.
Employees
711
Change (1Y)
102
Growth (1Y)
16.75%
Revenue / Employee
867.88K GBP
Profits / Employee
-1.71K GBP
Market Cap
6.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 711 | 102 | 16.75% |
| Sep 30, 2024 | 609 | 84 | 16.00% |
| Sep 30, 2023 | 525 | 128 | 32.24% |
| Sep 30, 2022 | 397 | 68 | 20.67% |
| Sep 30, 2021 | 329 | 97 | 41.81% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Arrowhead Pharmaceuticals News
- 4 days ago - Arrowhead (ARWR) Stock Sees 9.7% Rise Following Market Activity - GuruFocus
- 5 days ago - Arrowhead Pharmaceuticals (ARWR) Gains FDA Breakthrough Therapy Designation - GuruFocus
- 6 days ago - Arrowhead Pharmaceuticals gets FDA Breakthrough Therapy status for plozasiran - Seeking Alpha
- 6 days ago - Arrowhead (ARWR) Gains FDA Breakthrough Therapy Status for Plozasiran - GuruFocus
- 6 days ago - Arrowhead Pharma (ARWR): HC Wainwright Raises Price Target to $85 | ARWR Stock News - GuruFocus
- 6 days ago - Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia - Business Wire
- 6 days ago - Insider Sell: Mauro Ferrari Sells 8,750 Shares of Arrowhead Pharmaceuticals Inc (ARWR) - GuruFocus
- 6 days ago - Arrowhead Pharmaceuticals to Participate in Upcoming December 2025 Conferences - Business Wire